Skip to content
Buy This GLP
← Research
Evidence

Can You Take a GLP-1 Before Heart Surgery?

The surgical team can advise on your current prescription. Trials that gave liraglutide around heart surgery studied a separate question about blood sugar.

Editorial profile: Wesley JenkinsBuy This GLP Editorial Team4 min read
Liraglutide in heart surgery: risk ratios and 95% confidence intervalsno effect30-day deathany complicationcardiac eventshypoglycemianausea, vomitingFour trials, 446 randomized patients. Horizontal axis uses a log scale.

If you take a GLP-1 and have heart surgery planned, tell your surgeon and anesthesia team which medicine you take and when you last took it. They can tell you whether to continue or pause it. The American Diabetes Association advises an individualized plan based on why you take the medicine, symptoms, and the type and urgency of surgery and anesthesia [4].

Why the anesthesia team needs to know

Our guide to GLP-1 medicines before surgery explains how the team weighs delayed stomach emptying and blood sugar management. Wegovy’s U.S. label reports rare cases of aspiration during general anesthesia or deep sedation despite fasting. The label says available data are insufficient to determine whether changing fasting instructions or temporarily stopping the drug reduces retained stomach contents [5].

What trials of liraglutide during heart surgery found

In GLOBE, researchers randomly assigned 278 cardiac surgery patients to liraglutide or placebo. They analyzed the 261 participants who received at least one study injection. Extra insulin was needed during surgery by 55 of 129 patients (43%) on liraglutide and 80 of 132 (61%) on placebo. The trial excluded people already taking a GLP-1, so it cannot answer whether to continue an existing prescription[2].

Our guide to GLP-1 medicines and low blood sugar explains why other medicines matter when interpreting hypoglycemia. In GLOLIA, 70 people with type 2 diabetes undergoing elective cardiac surgery were assigned to insulin plus liraglutide or insulin alone. The combination improved a measure of how close glucose stayed to the treatment target and required fewer insulin adjustments [3].

What the pooled evidence says about complications

A 2026 review identified seven reports from four randomized trials with 446 patients. These trials compared perioperative liraglutide with placebo or usual insulin-based care. There was one death in 161 people receiving liraglutide and three in 160 controls among studies reporting 30-day mortality. The risk ratio was 0.42, with a 95% confidence interval of 0.06–2.81 [1].

The estimates for postoperative complications, cardiac events, low blood sugar and nausea or vomiting were also inconclusive. For example, the risk ratio for nausea or vomiting was 3.01, with a 95% confidence interval of 0.26–35.27[1].

Frequently asked

Should you stop a GLP-1 before heart surgery?
Ask your surgeon and anesthesia team. They weigh factors such as the medicine, symptoms, glucose management, and the urgency and type of procedure.
What did liraglutide do in the cardiac surgery trials?
In GLOBE, fewer people needed extra insulin during surgery when the hospital gave liraglutide. The pooled trials did not establish whether liraglutide changes the risk of serious complications after surgery.

Sources

  1. [1] Gamal I, et al. (2026). Safety and Glycemic Efficacy of Perioperative Liraglutide in Cardiac Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Cardiology in Review. PMID 42693519
  2. [2] Hulst AH, et al. (2020). Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial Diabetes, Obesity and Metabolism. PMID 31749275
  3. [3] Makino H, et al. (2019). Addition of low-dose liraglutide to insulin therapy is useful for glycaemic control during the peri-operative period: effect of glucagon-like peptide-1 receptor agonist therapy on glycaemic control in patients undergoing cardiac surgery (GLOLIA study) Diabetic Medicine. PMID 31335979
  4. [4] American Diabetes Association Professional Practice Committee (2026). Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 Diabetes Care. Source
  5. [5] Novo Nordisk (2026). Wegovy prescribing information, section 5.9 DailyMed, U.S. National Library of Medicine. Source

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence